• Explore /
  • Poster
  • / Clinical efficacy and biomarker analysis of pucotenlimab (HX008) in patients with previously treated advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A single-arm, multicenter, phase 2 study.

Clinical efficacy and biomarker analysis of pucotenlimab (HX008) in patients with previously treated advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A single-arm, multicenter, phase 2 study.

Abstract Poster

Authors

null

Bo Zhang

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;

Bo Zhang , Yan Song , Suxia Luo , Xianli Yin , Enxiao Li , Hui Wang , Yifu He , Zhihui Liu , Qingxia Fan , Xinjun Liang , Yongqian Shu , Yunpeng Liu , Nong Xu , Shu Zhang , Zhixiang Zhuang , Jingdong Zhang , Xiaoge Kou , Fen Wang , Xiaodong Zhu , Jing Huang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03704246

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 799)

DOI

10.1200/JCO.2023.41.4_suppl.799

Abstract #

799

Poster Bd #

M14

Abstract Disclosures

Similar Posters

First Author: Jian Li

First Author: Dung T. Le

First Author: Dung T. Le

First Author: Jiajian Liu